Clinical features, BTD gene mutations, and their functional studies of eight symptomatic patients with biotinidase deficiency from Southern China. Issue 3 (23rd January 2018)

• Record Type: Journal Article
• Authors: Liu, Zongcai; Zhao, Xiaoyuan; Sheng, Huiying; Cai, Yanna; Yin, Xi; Chen, Xiaodan; Su, Ling; Lu, Zhikun; Zeng, Chunhua; Li, Xiuzhen; Liu, Li
• Is Part Of: American journal of medical genetics. Volume 176:Issue 3(2018)
• Page Start: 589
• Page End: 596
• Publication Date: 2018-01-23
• Subjects: biotinidase deficiency -- clinical features -- definitive diagnosis -- functional study -- gene mutations; Medical genetics -- Periodicals; 616.14205
• DOI: 10.1002/ajmg.a.38601
• Languages: English
• ISSNs: 1552-4825

Abstract

Abstract : Biotinidase (BTD) deficiency is a rare autosomal recessive metabolic disease, which develops neurological and cutaneous symptoms because of the impaired biotin recycling. Pathogenic mutations on BTD gene cause BTD deficiency. Clinical features and mutation analysis of Chinese children with BTD deficiency were rarely described. Herein, for the first time, we reported the clinical features, BTD gene mutations and their functional studies of eight symptomatic children with BTD deficiency from southern China. Fatigue, hypotonia, proximal muscular weakness, hearing deficits, rash and respiratory problems are common clinical phenotype of our patients. Seizures are observed only in patients with profound BTD deficiency. Five novel mutations were detected, among which c.637delC (H213TfsTer51) was found in 50% of our patients and might be considered as a common mutation. In vitro studies confirmed three mild mutations c.1368A>C (Q456H), c.1613G>A (R538H), and c.644T>A (L215H) which retained 10–30% of wild type enzyme activity, and six severe mutations c.235C>T (R79C), c.1271G>C (C424S), c.1412G>A (C471Y), c.637delC (H213TfsTer51), c.395T>G (M132W), c.464T>C (L155P), and c.1493dupT (L498FfsTer13) which retained <10% of wild type enzyme activity. c.1330G>C (D444H) decreased the protein expression but not activity of BTD enzyme, and H213TfsTer51 was structurally damaging while L498FfsTer13 was functionally damaging. These results will be helpful in establishing the definitive diagnosis of BTD deficiency at the gene level, offering appropriate genetic counseling, and providing clues to structure/function relationships of the enzyme.